Hunan Er-Kang Pharmaceutical Co., Ltd, at its Annual General Meeting of 2022 held on 18 May 2023, approved 2022 profit distribution plan. The detailed profit distribution plan are as follows: Cash dividend/10 shares (tax included) of CNY 0.30000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 CNY | -3.51% | -8.33% | -31.46% |
1st Jan change | Capi. | |
---|---|---|
-31.46% | 649M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- 300267 Stock
- News Hunan Er-Kang Pharmaceutical Co., Ltd
- Hunan Er-Kang Pharmaceutical Co., Ltd Approves 2022 Profit Distribution Plan